Siwei Ju

567 total citations
17 papers, 355 citations indexed

About

Siwei Ju is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Siwei Ju has authored 17 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Siwei Ju's work include Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Siwei Ju is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers) and Cancer Cells and Metastasis (3 papers). Siwei Ju collaborates with scholars based in China, Germany and United States. Siwei Ju's co-authors include Linbo Wang, Yongxia Chen, Jichun Zhou, Zhaoqing Li, Cong Chen, Feiyang Ji, Xun Zhang, Lin Xu, Xun Zhang and Misha Mao and has published in prestigious journals such as Nature Communications, Cell Death and Disease and Frontiers in Oncology.

In The Last Decade

Siwei Ju

17 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Siwei Ju China	9	195	154	92	79	44	17	355
Jiangbo Ren China	13	216 1.1×	102 0.7×	78 0.8×	119 1.5×	41 0.9×	31	423
Ririno Honma Japan	13	210 1.1×	141 0.9×	164 1.8×	64 0.8×	32 0.7×	20	363
Nengquan Sheng China	9	251 1.3×	143 0.9×	94 1.0×	53 0.7×	37 0.8×	17	366
Xinjian Huang China	13	190 1.0×	112 0.7×	172 1.9×	68 0.9×	23 0.5×	25	395
Ellen C. de Heer Netherlands	7	168 0.9×	139 0.9×	111 1.2×	70 0.9×	41 0.9×	8	345
Qianling Zhu China	7	273 1.4×	96 0.6×	128 1.4×	61 0.8×	18 0.4×	8	383
Suan Sun China	12	268 1.4×	197 1.3×	75 0.8×	44 0.6×	40 0.9×	24	403
Zhen Cai China	12	176 0.9×	219 1.4×	234 2.5×	66 0.8×	36 0.8×	18	437
Xiujie Xie United States	10	272 1.4×	178 1.2×	149 1.6×	40 0.5×	29 0.7×	14	411
Yunwei Han China	13	293 1.5×	166 1.1×	116 1.3×	86 1.1×	53 1.2×	28	453

Countries citing papers authored by Siwei Ju

Since Specialization

Citations

This map shows the geographic impact of Siwei Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Ju more than expected).

Fields of papers citing papers by Siwei Ju

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siwei Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Ju. The network helps show where Siwei Ju may publish in the future.

Co-authorship network of co-authors of Siwei Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Siwei Ju. A scholar is included among the top collaborators of Siwei Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siwei Ju. Siwei Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Ju, Siwei, Yongxia Chen, Jun Shen, et al.. (2025). 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer. Biomarkers in Medicine. 19(9). 317–328. 1 indexed citations

Ju, Siwei, Xixi Lin, Jichun Zhou, et al.. (2025). TET-mediated 5hmC in breast cancer: mechanism and clinical potential. Epigenetics. 20(1). 2473250–2473250. 3 indexed citations

Zhu, Huihui, Qiuhong Liu, Lingjian Zhang, et al.. (2024). CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. Journal of Experimental & Clinical Cancer Research. 43(1). 245–245. 11 indexed citations

Hu, Dengdi, Wenying Zhuo, Feiyang Ji, et al.. (2023). Biological differences between normal and cancer-associated fibroblasts in breast cancer. Heliyon. 9(9). e19803–e19803. 4 indexed citations

Xie, Shuduo, Siwei Ju, Xun Zhang, et al.. (2023). A retrospective comparative study on the diagnostic efficacy and the complications: between CassiII rotational core biopsy and core needle biopsy. Frontiers in Oncology. 13. 1067246–1067246. 1 indexed citations

Ju, Siwei, et al.. (2023). Digital Twin of a Driver-in-the-Loop Race Car Simulation With Contextual Reinforcement Learning. IEEE Robotics and Automation Letters. 8(7). 4107–4114. 5 indexed citations

Ju, Siwei, et al.. (2023). An Adaptive Human Driver Model for Realistic Race Car Simulations. IEEE Transactions on Systems Man and Cybernetics Systems. 53(11). 6718–6730. 2 indexed citations

Mao, Misha, Yunlu Jia, Yongxia Chen, et al.. (2022). HJURP regulates cell proliferation and chemo-resistance via YAP1/NDRG1 transcriptional axis in triple-negative breast cancer. Cell Death and Disease. 13(4). 396–396. 24 indexed citations

Ju, Siwei, Cong Chen, Lin Xu, et al.. (2022). Detection of circulating tumor cells: opportunities and challenges. Biomarker Research. 10(1). 58–58. 116 indexed citations

10.

Zhang, Xun, Jiahang Zhang, Xixi Lin, et al.. (2022). The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers. Frontiers in Genetics. 13. 1005522–1005522. 28 indexed citations

11.

Chen, Cong, Bojian Xie, Zhaoqing Li, et al.. (2022). Fascin enhances the vulnerability of breast cancer to erastin-induced ferroptosis. Cell Death and Disease. 13(2). 44 indexed citations

12.

Mao, Misha, Yongxia Chen, Jingjing Yang, et al.. (2022). Modification of PLAC8 by UFM1 affects tumorous proliferation and immune response by impacting PD-L1 levels in triple-negative breast cancer. Journal for ImmunoTherapy of Cancer. 10(12). e005668–e005668. 28 indexed citations

13.

Zhou, Qiyin, Wenyu Lin, Chaoqun Wang, et al.. (2022). Neddylation inhibition induces glutamine uptake and metabolism by targeting CRL3SPOP E3 ligase in cancer cells. Nature Communications. 13(1). 51 indexed citations

14.

Xu, Ling, Lijie Chen, Jida Chen, et al.. (2021). Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine. Frontiers in Cell and Developmental Biology. 9. 744990–744990. 13 indexed citations

15.

Li, Zhaoqing, Wenying Zhuo, Lini Chen, et al.. (2021). Establishment and Characterization of a HER2-Positive Cell Line Derived From the Pleural Effusion of a Drug-Resistant Breast Cancer Patient. Frontiers in Cell and Developmental Biology. 9. 680968–680968. 3 indexed citations

16.

Mao, Misha, Yifan Cheng, Jingjing Yang, et al.. (2021). Multifaced roles of PLAC8 in cancer. Biomarker Research. 9(1). 73–73. 20 indexed citations

17.

Ju, Siwei, et al.. (2017). Discussion on the Direction of Undergraduate Electro-Mechanical Integration for Local Economy. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact